Revitalizing The Pharmaceutical Business
Download Revitalizing The Pharmaceutical Business full books in PDF, epub, and Kindle. Read online free Revitalizing The Pharmaceutical Business ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : R. B. Smarta |
| Publisher | : SAGE Publications Pvt. Limited |
| Total Pages | : 304 |
| Release | : 1999-12-08 |
| Genre | : Business & Economics |
| ISBN | : |
In this path-breaking book, Dr R B Smarta explores new and innovative marketing responses to the changing realities in order to inject new life into pharmaceutical organizations. The book discusses how pharmaceutical companies can acquire, develop and nurture their marketing assets. Dr Smarta emphasizes the need to be creative in communicating to one`s customers. He suggests some new unconventional sales promotion avenues while emphasizing the need to reach customers through well-defined distribution channels.
| Author | : Edmund Valentine |
| Publisher | : |
| Total Pages | : 240 |
| Release | : 2012-07-02 |
| Genre | : |
| ISBN | : 9780984047826 |
Innovate and prosper, stagnate and perish. The 13th Edition of Trends Shaping U.S. Pharmaceutical Industry Strategiesreport is designed to challenge senior management thinking and strategic assumptions - to force the hard questions that make the difference between status quo strategies that doom companies and proactive strategies that leverage resources to create increasing shareholder returns. The "Trends" report is designed to challenge conventional thinking, fight "Group Think", inject fresh/different ways of looking at pharmaceuticals...and to question product development, marketing, business development, and company strategies. It is an effective tool for the orientation of senior management employees new to the pharmaceuticals industry and serves as an excellent reference source for presentations and issues discussions.& ; & ; & ;The 13th Edition of the Trends Shaping U.S. Pharmaceuticals Industry Strategies report provides insights how the transformation of the respective United States healthcare industry market segments/stakeholders will redefine how drugs are identified, developed, reimbursed, launched, marketed, prescribed, dispensed, and taken by patients. The period to 2020 presents opportunities for companies to redefine industry norms in select therapeutic and/or product categories to create a competitive advantage.& ; & ;U.S. Pharmaceuticals represents an industry undergoing redefinition and revitalization. The 2012 to 2020 period will be typified by industry discontinuities, innovation and change. What worked in the past will not work in the future. Pharmaceutical industry norms in 2020 will be radically different than they were at the end of 2011.& ; & ;Objective, fact-based strategic planning will be the difference between success and failure for most pharmaceutical, biotechnology and generics drug companies. Strategically managed companies will anticipate and capitalize on industry change, innovate and prosper; the remainder will be broken up, acquired, merged or driven out of business. The 13th Edition of the Trends Shaping U.S. Pharmaceuticals Industry Strategies report is designed to challenge internal assumptions and corporate strategies to assist management in refining strategies to better position the company to capitalize on industry change.
| Author | : John Lidstone |
| Publisher | : Taylor & Francis |
| Total Pages | : 169 |
| Release | : 2017-07-05 |
| Genre | : Business & Economics |
| ISBN | : 1351919768 |
Marketing in the pharmaceutical and healthcare sector requires a particular set of skills; its intricacies mean planning is an essential prerequisite. The marketing planning system described in this book has been designed to enable marketing and product executives to produce a plan which serves as a dynamic management tool which will help them to get from where they are now to where they want to be next year and thereafter. Now in its second edition, this bestselling book has become the standard text for all product managers, marketing managers and directors working in this demanding industry. John Lidstone and Janice MacLennan have updated the book to embrace best current practice. A new orientation to external analysis and a reworking of the application of SWOT analysis, along with fresh material on sales forecasting and strategy implementation, bring the book up to date with current thinking and industry trends. Marketing Planning for the Pharmaceutical Industry is based on real life experience built up over many years. Each chapter takes the reader through the sequential stages of planning so that by the end they will be able to produce a practical plan ready for implementation. It is the only book of this type which tailors marketing to those working in the sector and as such is a unique, invaluable and indispensable resource.
| Author | : Raja B Smarta |
| Publisher | : Pharmamed Press |
| Total Pages | : 392 |
| Release | : 2019-10-28 |
| Genre | : Medical |
| ISBN | : 9789386819772 |
The pharmaceutical industry today is faced with significant challenges owing to the volatile and competitive business environment. For both survival and growth, it is imperative for pharmaceutical organizations to rethink their way of doing business, especially their marketing. The book 'Strategic Pharmaceutical Marketing' thus, focuses on the practice of marketing prescription medications. It highlights the political, economical, social, technological and regulatory perspectives of pharmaceutical marketing, examines consumers, prescribers and explores positive marketing, pricing and distribution strategies. It provides a detailed explanation of pharmaceutical marketing as well as provides real-world case studies to demonstrate certain aspects. The book is scripted from an industry and academic perspective. It allows pharmaceutical marketers to have a detailed understanding of the functions of pharmaceutical marketing thus, helping them plan their marketing strategies in a more accurate and precise way. Individuals entering the field of marketing pharmaceutical products - sales personnel, assistant product managers, marketing staff as well as policy makers will achieve an in-depth understanding of the pharmaceutical industry. The marketing models described in the book along with promotion, distribution, and pricing scenarios, competitive analysis and market research will benefit the pharmaceutical marketer as a whole The book would provoke you to think of the surface and latent problems in new ways, find out different and more imaginative solutions and reflect on different options for tomorrow to scope with the chang ing situations. The book also deals with pharmaceutical marketing financial analysis to help measure the success of the marketing decisions and return on investment. This book, written in a reader-friendly style will help the marketers and CEOs of the pharmaceutical industry to bring about synergy in their strategies and operations, by thinking about the options, and looking at innovation as an important ingredient for progress. It will also help to generate cost-effective and new marketing approaches. Professionals in healthcare as also marketing executives in other industries will also find the book useful.
| Author | : Meir Statman |
| Publisher | : A E I Press |
| Total Pages | : 106 |
| Release | : 1983 |
| Genre | : Business & Economics |
| ISBN | : |
| Author | : Institute of Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 225 |
| Release | : 1991-02-01 |
| Genre | : Medical |
| ISBN | : 030904491X |
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
| Author | : Arthur G. Cook |
| Publisher | : CRC Press |
| Total Pages | : 323 |
| Release | : 2016-03-03 |
| Genre | : Business & Economics |
| ISBN | : 1317134109 |
Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as well as the multitude of decision makers and executives who rely on forecasts in their decision making. In virtually every decision, a pharmaceutical executive considers some type of forecast. This process of predicting the future is crucial to many aspects of the company - from next month's production schedule, to market estimates for drugs in the next decade. The pharmaceutical forecaster needs to strike a delicate balance between over-engineering the forecast - including rafts of data and complex ’black box’ equations that few stakeholders understand and even fewer buy into - and an overly simplistic approach that relies too heavily on anecdotal information and opinion. Arthur G. Cook's highly pragmatic guide explains the basis of a successful balanced forecast for products in development as well as currently marketed products. The author explores the pharmaceutical forecasting process; the varied tools and methods for new product and in-market forecasting; how they can be used to communicate market dynamics to the various stakeholders; and the strengths and weaknesses of different forecast approaches. The text is liberally illustrated with tables, diagrams and examples. The final extended case study provides the reader with an opportunity to test out their knowledge. The second edition has been updated throughout and includes a brand new chapter focusing on specialized topics such as forecasting for orphan drugs and biosimilars.
| Author | : Maureen Mackintosh |
| Publisher | : Springer |
| Total Pages | : 353 |
| Release | : 2016-02-03 |
| Genre | : Political Science |
| ISBN | : 1137546476 |
This book is open access under a CC-BY license. The importance of the pharmaceutical industry in Sub-Saharan Africa, its claim to policy priority, is rooted in the vast unmet health needs of the sub-continent. Making Medicines in Africa is a collective endeavour, by a group of contributors with a strong African and more broadly Southern presence, to find ways to link technological development, investment and industrial growth in pharmaceuticals to improve access to essential good quality medicines, as part of moving towards universal access to competent health care in Africa. The authors aim to shift the emphasis in international debate and initiatives towards sustained Africa-based and African-led initiatives to tackle this huge challenge. Without the technological, industrial, intellectual, organisational and research-related capabilities associated with competent pharmaceutical production, and without policies that pull the industrial sectors towards serving local health needs, the African sub-continent cannot generate the resources to tackle its populations' needs and demands. Research for this book has been selected as one of the 20 best examples of the impact of UK research on development. See http://www.ukcds.org.uk/the-global-impact-of-uk-research for further details.
| Author | : United States. Congress. Senate. Committee on Labor and Human Resources |
| Publisher | : |
| Total Pages | : 96 |
| Release | : 1996 |
| Genre | : Medical |
| ISBN | : |
| Author | : Joey Reiman |
| Publisher | : Rowman & Littlefield |
| Total Pages | : 209 |
| Release | : 2001 |
| Genre | : Creative ability in business |
| ISBN | : 1563524694 |
Can one idea be worth a million dollars? Of course. But what is a million-dollar idea worth if it is poorly executed? In this ground-breaking, paradigm-shifting book, creative genius Joey Reiman presents a convincing argument for the value of raw ideas.
